Quantitative Easing

Showing 565 articles
Business

Guardian Pharmacy Services: Is the Stock Fairly Valued After Recent Gains?

A deep dive into Guardian Pharmacy Services (NYSE:GRDN) using a discounted cash flow model suggests its current share price is hovering close to its estimated intrinsic value. While the analysis provides a quantitative benchmark, investors are cautioned that valuation is just one piece of the puzzle in a complex and regulated healthcare sector.

Business

Microsoft's AI Bet Drains Cash, But Analysts See a Buying Opportunity

Microsoft's free cash flow took a significant hit last quarter due to soaring capital expenditures on AI infrastructure. While the drop spooked some investors, management signals a near-term easing, and analysts argue the market's reaction may have overlooked the long-term payoff and underlying financial strength.